Trials / Completed
CompletedNCT00563732
Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin
An Open-Label, Nonrandomized Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Lecozotan SR and a Single Oral Dose of Digoxin When Administered Orally to Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Primary: To evaluate the effects of multiple doses of lecozotan SR on the PK profile of a single dose of digoxin in healthy adult subjects. Secondary: To assess the safety and tolerability of the coadministration of lecozotan SR and digoxin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lecozotan |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2007-11-26
- Last updated
- 2008-09-09
Source: ClinicalTrials.gov record NCT00563732. Inclusion in this directory is not an endorsement.